France’s Sanofi faces an EU antitrust probe.

Sanofi holds a dominant market position; the European Commission said it misrepresented rival flu vaccine Fluad’s clinical evidence to doctors in Germany and France.

Sanofi said it is cooperating fully; fines can reach 10% of global revenues if found in breach.

Sources: Financial Times News